-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Enveric Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Enveric Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.9M, a 67% increase year-over-year.
- Enveric Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$10.2M, a 64.2% increase year-over-year.
- Enveric Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$16.4M, a 40% increase from 2022.
- Enveric Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$27.4M, a 57.6% increase from 2021.
- Enveric Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$64.6M, a 1050% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)